News & Articles

Expanded partnership aims to advance precision oncology through distributed NGS‑based tissue and liquid biopsy testing

The latest solution to enable comprehensive genomic profiling of tumors was presented at the annual meeting of the Association of Molecular Pathology

Incorporating the technology and chemistry of the NovaSeq™ X Series, the MiSeq i100 will help to fuel the next era of genomics growth and discovery

The new reagent kits aim to make whole genome sequencing more accessible and affordable for labs of all sizes

Whole-genome sequencing offers the ability to reduce pediatric diagnostic odysseys which cost at least $14 billion annually in the U.S.

llumina's COVIDSeq aims to generate information about the genomic sequence of the virus

Extended RAS Panel helps identify colorectal cancer patients eligible for Amgen’s Vectibix

Illumina becomes primary vendor of tumor variant interpretation and reporting software for pioneering population sequencing project

Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening